ASPREE Cancer Endpoints Study

NCT01968798 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

14500

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DRUG: Aspirin
DRUG: Placebo

Sponsor

Hennepin Healthcare Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]